Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$224.73 - $338.64 $271,249 - $408,738
-1,207 Closed
0 $0
Q1 2022

May 18, 2022

BUY
$277.25 - $366.29 $69,867 - $92,305
252 Added 26.39%
1,207 $409,000
Q4 2021

Feb 14, 2022

SELL
$300.63 - $371.35 $155,425 - $191,987
-517 Reduced 35.12%
955 $344,000
Q3 2021

Nov 15, 2021

BUY
$310.19 - $376.2 $69,792 - $84,645
225 Added 18.04%
1,472 $476,000
Q2 2021

Aug 16, 2021

BUY
$262.71 - $351.17 $327,599 - $437,908
1,247 New
1,247 $389,000
Q1 2021

May 17, 2021

SELL
$285.92 - $355.13 $467,193 - $580,282
-1,634 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$251.88 - $324.2 $129,970 - $167,287
516 Added 46.15%
1,634 $530,000
Q3 2020

Nov 12, 2020

SELL
$255.22 - $317.0 $530,602 - $659,043
-2,079 Reduced 65.03%
1,118 $310,000
Q2 2020

Aug 14, 2020

BUY
$141.4 - $257.09 $452,055 - $821,916
3,197 New
3,197 $772,000
Q1 2020

May 14, 2020

SELL
$130.51 - $196.01 $695,096 - $1.04 Million
-5,326 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$159.31 - $223.54 $209,014 - $293,284
-1,312 Reduced 19.76%
5,326 $909,000
Q3 2019

Nov 14, 2019

SELL
$175.89 - $279.23 $188,378 - $299,055
-1,071 Reduced 13.89%
6,638 $1.13 Million
Q2 2019

Aug 14, 2019

BUY
$250.96 - $284.94 $944,864 - $1.07 Million
3,765 Added 95.46%
7,709 $2.04 Million
Q1 2019

May 14, 2019

SELL
$276.39 - $362.25 $16.5 Million - $21.6 Million
-59,751 Reduced 93.81%
3,944 $1.1 Million
Q4 2018

Feb 14, 2019

SELL
$281.08 - $444.25 $1.04 Million - $1.65 Million
-3,704 Reduced 5.5%
63,695 $20.7 Million
Q3 2018

Nov 14, 2018

SELL
$354.53 - $449.75 $2.18 Million - $2.76 Million
-6,136 Reduced 8.34%
67,399 $30 Million
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $19.2 Million - $30.8 Million
69,073 Added 1548.03%
73,535 $28.1 Million
Q1 2018

May 14, 2018

BUY
$192.49 - $295.85 $858,890 - $1.32 Million
4,462 New
4,462 $1.3 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.